Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…

$1 trillion wipeout: Market rout punishes mega-cap tech

[ad_1] Traders work on the floor of the New York Stock Exchange during morning trading on…

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Job growth totals 114,000 in July, much less than expected, as unemployment rate rises to 4.3%

[ad_1] Job growth in the U.S. slowed much more than expected during July and the unemployment…

Here’s everything you need to know about Friday’s big jobs report

[ad_1] People line up as they wait for the JobNewsUSA.com South Florida Job Fair to open…

Markets are clamoring for the Fed to start cutting soon: ‘What is it they’re looking for?’

[ad_1] Federal Reserve Chairman Jerome Powell arrives to speak at a news conference following a Federal…

Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction

[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

[ad_1] Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance,…

Fed holds rates steady and notes progress on inflation

[ad_1] WASHINGTON – Federal Reserve officials on Wednesday held short-term interest rates steady but indicated that…

Stocks making the biggest moves premarket: Pinterest, Match Group, Advanced Micro Devices and more

[ad_1] Check out the companies making headlines before the bell: DuPont — Shares popped 5% on…

Private payroll growth slowed to 122,000 in July, less than expected, ADP says

[ad_1] A “Now Hiring” sign is seen at a FedEx location on Broadway on June 07,…

Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says

[ad_1] The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington,…

Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda

[ad_1] The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb.…

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted…

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…

Newseum Global